- Home
- REKR vs EPRX Comparison
REKR vs EPRX Comparison
Compare REKR & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- EPRX
- Stock Information
- Founded
- REKR 2017
- EPRX 2011
- Country
- REKR United States
- EPRX Canada
- Employees
- REKR N/A
- EPRX N/A
- Industry
- REKR Telecommunications Equipment
- EPRX
- Sector
- REKR Telecommunications
- EPRX
- Exchange
- REKR Nasdaq
- EPRX NYSE
- Market Cap
- REKR 115.1M
- EPRX 130.0M
- IPO Year
- REKR N/A
- EPRX N/A
- Fundamental
- Price
- REKR $0.87
- EPRX $3.28
- Analyst Decision
- REKR
- EPRX Strong Buy
- Analyst Count
- REKR 0
- EPRX 1
- Target Price
- REKR N/A
- EPRX $9.00
- AVG Volume (30 Days)
- REKR 3.7M
- EPRX 12.7K
- Earning Date
- REKR 03-31-2025
- EPRX 03-20-2025
- Dividend Yield
- REKR N/A
- EPRX N/A
- EPS Growth
- REKR N/A
- EPRX N/A
- EPS
- REKR N/A
- EPRX N/A
- Revenue
- REKR $43,817,000.00
- EPRX N/A
- Revenue This Year
- REKR $33.40
- EPRX N/A
- Revenue Next Year
- REKR $41.09
- EPRX N/A
- P/E Ratio
- REKR N/A
- EPRX N/A
- Revenue Growth
- REKR 44.46
- EPRX N/A
- 52 Week Low
- REKR $0.78
- EPRX $2.20
- 52 Week High
- REKR $2.67
- EPRX $4.48
- Technical
- Relative Strength Index (RSI)
- REKR 34.15
- EPRX N/A
- Support Level
- REKR $0.99
- EPRX N/A
- Resistance Level
- REKR $1.18
- EPRX N/A
- Average True Range (ATR)
- REKR 0.09
- EPRX 0.00
- MACD
- REKR 0.01
- EPRX 0.00
- Stochastic Oscillator
- REKR 13.98
- EPRX 0.00
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.